Enlarged Pores Clinical Trial
Official title:
The Efficacy and Safety of Erbium:Yttrium Aluminum Garnet Laser for Treatment of Enlarged Pores: A Pilot Study
To investigate the efficacy of Erbium:Yttrium aluminum garnet laser (Er:YAG) in the treatment of enlarged pores.
- Enlarged pores are caused by multifactorial factors such as sex, genetics, aging, etc.
- The gold of the treatment is to recollagenesis of the dermis and resurfacing of the
epidermis.
- Modalities that have been proved on their efficacy for enlarged pores treatment
included topical retinoic acid, chemical peeling, intense pulsed light, radiofrequency
device, laser such as Q-switched and Long Pulsed Neodymium-Doped
Yttrium-Aluminum-Garnet (Nd:YAG) 1,064nm, Long pulse duration pulsed dye laser 595nm,
etc.
- Er:YAG laser is an ablative laser which creates both recollagenesis and resurfacing. It
ha been proved to be safe and effective in the treatment of atrophic acne scar.
- However, the efficacy of this laser for enlarged treatment has not yet been
established.
;
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05097157 -
Study To Assess A Radiofrequency Microneedling Device For Dermatologic Conditions
|
N/A | |
| Completed |
NCT05254210 -
Feasibility Study To Collect Safety And Preliminary Efficacy Data For A Radiofrequency Microneedling Device
|
N/A | |
| Active, not recruiting |
NCT05784363 -
A Study of NT 201 in the Treatment of Enlarged Pores and Excessive Sebum Production in the Face
|
Phase 1 | |
| Recruiting |
NCT04471948 -
The Safety and Efficacy of 1064-nm Picosecond Laser With Microlens Array for Pore Tightening; a Pilot Study
|
N/A | |
| Recruiting |
NCT05987319 -
Feasibility Study to Collect and Assess Safety Data for a Radiofrequency Microneedling Device for Electrocoagulation and Hemostasis of Soft Tissues for Dermatologic Conditions
|
N/A | |
| Active, not recruiting |
NCT06293755 -
Microneedle Patch With Botulinum Toxin in Management of Enlarged Facial Pores
|
Phase 3 |